UCHIYAMA HOLDINGSLtd Past Earnings Performance
Past criteria checks 1/6
UCHIYAMA HOLDINGSLtd's earnings have been declining at an average annual rate of -16.8%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been declining at an average rate of 1% per year. UCHIYAMA HOLDINGSLtd's return on equity is 1.7%, and it has net margins of 0.7%.
Key information
-16.8%
Earnings growth rate
-16.8%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | -1.0% |
| Return on equity | 1.7% |
| Net Margin | 0.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How UCHIYAMA HOLDINGSLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 28,842 | 213 | 992 | 0 |
| 31 Dec 23 | 28,405 | 88 | 1,006 | 0 |
| 30 Sep 23 | 27,934 | -120 | 1,007 | 0 |
| 30 Jun 23 | 27,279 | -466 | 1,024 | 0 |
| 31 Mar 23 | 26,911 | -400 | 1,029 | 0 |
| 31 Dec 22 | 26,160 | -788 | 1,031 | 0 |
| 30 Sep 22 | 26,755 | -202 | 1,097 | 0 |
| 30 Jun 22 | 25,984 | -175 | 1,091 | 0 |
| 31 Mar 22 | 24,958 | -650 | 1,111 | 0 |
| 31 Dec 21 | 24,703 | -577 | 1,100 | 0 |
| 30 Sep 21 | 23,556 | -2,429 | 1,111 | 0 |
| 30 Jun 21 | 23,922 | -2,158 | 1,089 | 0 |
| 31 Mar 21 | 23,795 | -2,231 | 1,121 | 0 |
| 31 Dec 20 | 24,701 | -2,532 | 1,135 | 0 |
| 30 Sep 20 | 25,417 | -1,049 | 1,122 | 0 |
| 30 Jun 20 | 26,340 | -937 | 1,180 | 0 |
| 31 Mar 20 | 30,295 | 2 | 1,182 | 0 |
| 31 Dec 19 | 30,398 | 1,025 | 1,161 | 0 |
| 30 Sep 19 | 30,361 | 1,385 | 1,189 | 0 |
| 30 Jun 19 | 30,173 | 1,531 | 1,120 | 0 |
| 31 Mar 19 | 27,209 | 1,102 | 1,157 | 0 |
| 31 Dec 18 | 27,035 | 1,077 | 1,147 | 0 |
| 30 Sep 18 | 26,723 | 818 | 1,148 | 0 |
| 30 Jun 18 | 26,637 | 773 | 1,204 | 0 |
| 31 Mar 18 | 26,402 | 808 | 1,151 | 0 |
| 31 Dec 17 | 26,246 | 257 | 1,175 | 0 |
| 30 Sep 17 | 26,283 | 292 | 1,167 | 0 |
| 30 Jun 17 | 25,739 | 221 | 1,176 | 0 |
| 31 Mar 17 | 25,318 | 59 | 1,189 | 0 |
| 31 Dec 16 | 24,800 | 717 | 1,238 | 0 |
| 30 Sep 16 | 24,305 | 747 | 1,147 | 0 |
| 30 Jun 16 | 24,163 | 893 | 1,152 | 0 |
| 31 Mar 16 | 23,897 | 983 | 1,112 | 0 |
| 31 Dec 15 | 23,890 | 1,264 | 1,182 | 0 |
| 30 Sep 15 | 23,745 | 1,256 | 1,127 | 0 |
| 30 Jun 15 | 23,527 | 1,175 | 1,131 | 0 |
| 31 Mar 15 | 23,628 | 1,289 | 1,097 | 0 |
| 31 Dec 14 | 23,238 | 1,162 | 1,208 | 0 |
| 30 Sep 14 | 22,737 | 1,260 | 929 | 0 |
| 30 Jun 14 | 22,369 | 2,140 | 1,053 | 0 |
| 31 Mar 14 | 21,758 | 2,217 | 1,015 | 0 |
| 31 Dec 13 | 21,410 | 2,253 | 1,029 | 0 |
| 30 Sep 13 | 21,020 | 2,335 | 1,060 | 0 |
| 30 Jun 13 | 20,447 | 1,449 | 1,049 | 0 |
Quality Earnings: 6059 has a large one-off loss of ¥369.0M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 6059 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6059's earnings have declined by 16.8% per year over the past 5 years.
Accelerating Growth: 6059 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 6059 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (10.2%).
Return on Equity
High ROE: 6059's Return on Equity (1.7%) is considered low.